Omnaris Nasal Spray is indicated for the treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and children six years of age and older, and with perennial allergic rhinitis in adults and adolescents 12 years of age and older.
Adrian Adams, president and CEO of Sepracor, said: “We believe that Omnaris Nasal Spray is a strategically seamless fit with our proprietary portfolio of respiratory products.”